K. Anwar, S. Sanjaya, R. Ayu, and F. Sani, “Safety and Efficacy of Subretinal AAV-CRISPR/Cas9 Gene Editing for Rhodopsin-Mutant Retinitis Pigmentosa: A Phase I/IIa Dose-Escalation Triall”, sjo, vol. 8, no. 2, pp. 478-485, Jun. 2026.